127 related articles for article (PubMed ID: 24967065)
1. Matrix-mini-tablets of lornoxicam for targeting early morning peak symptoms of rheumatoid arthritis.
Mohd AH; Raghavendra Rao NG; Avanapu SR
Iran J Basic Med Sci; 2014 May; 17(5):357-69. PubMed ID: 24967065
[TBL] [Abstract][Full Text] [Related]
2. Formulation and evaluation of ileo-colonic targeted matrix-mini-tablets of Naproxen for chronotherapeutic treatment of rheumatoid arthritis.
Hadi MA; Raghavendra Rao NG; Srinivasa Rao A
Saudi Pharm J; 2016 Jan; 24(1):64-73. PubMed ID: 26903770
[TBL] [Abstract][Full Text] [Related]
3. Formulation and evaluation of mini-tablets-filled-pulsincap delivery of lornoxicam in the chronotherapeutic treatment of rheumatoid arthritis.
Hadi MA; Rao NG; Rao AS
Pak J Pharm Sci; 2015 Jan; 28(1):185-93. PubMed ID: 25553695
[TBL] [Abstract][Full Text] [Related]
4. Design and evaluation of gastroretentive levofloxacin floating mini-tablets-in-capsule system for eradication of Helicobacter pylori.
El-Zahaby SA; Kassem AA; El-Kamel AH
Saudi Pharm J; 2014 Dec; 22(6):570-9. PubMed ID: 25561871
[TBL] [Abstract][Full Text] [Related]
5. Dissolution enhancement and formulation of rapid-release lornoxicam mini-tablets.
Tawfeek HM; Saleem IY; Roberts M
J Pharm Sci; 2014 Aug; 103(8):2470-83. PubMed ID: 24995853
[TBL] [Abstract][Full Text] [Related]
6. Design and in vitro evaluation of novel sustained- release matrix tablets for lornoxicam based on the combination of hydrophilic matrix formers and basic pH-modifiers.
Hamza Yel-S; Aburahma MH
Pharm Dev Technol; 2010; 15(2):139-53. PubMed ID: 19895367
[TBL] [Abstract][Full Text] [Related]
7. Comparative study on the in vitro performance of blister molded and conventional lornoxicam immediate release liquitablets: accelerated stability study and anti-inflammatory and ulcerogenic effects.
El-Setouhy DA; Gamiel AA; Badawi AA; Osman AS; Labib DA
Pharm Dev Technol; 2017 Mar; 22(2):256-265. PubMed ID: 27494155
[TBL] [Abstract][Full Text] [Related]
8. Innovation of novel sustained release compression-coated tablets for lornoxicam: formulation and in vitro investigations.
Hamza Yel-S; Aburahma MH
Drug Dev Ind Pharm; 2010 Mar; 36(3):337-49. PubMed ID: 19722915
[TBL] [Abstract][Full Text] [Related]
9. Effect of HPMC - E15 LV premium polymer on release profile and compression characteristics of chitosan/ pectin colon targeted mesalamine matrix tablets and in vitro study on effect of pH impact on the drug release profile.
Newton AM; Lakshmanan P
Recent Pat Drug Deliv Formul; 2014 Apr; 8(1):46-62. PubMed ID: 24597626
[TBL] [Abstract][Full Text] [Related]
10. Lornoxicam gastro retentive floating matrix tablets: Design and in vitro evaluation.
Sathiyaraj S; Devi RD; Hari VB
J Adv Pharm Technol Res; 2011 Jul; 2(3):156-62. PubMed ID: 22171312
[TBL] [Abstract][Full Text] [Related]
11. Chronotherapeutic drug delivery from indomethacin compression coated tablets for early morning pain associated rheumatoid arthritis.
Sunil SA; Srikanth MV; Rao NS; Murthy KV
Curr Drug Deliv; 2013 Feb; 10(1):109-21. PubMed ID: 22974284
[TBL] [Abstract][Full Text] [Related]
12. Development of Biodegradable Injectable In situ Forming Implants for Sustained Release of Lornoxicam.
Christian R; Thakkar V; Patel T; Gohel M; Baldaniya L; Shah P; Pandya T; Gandhi T
Curr Drug Deliv; 2019; 16(1):66-78. PubMed ID: 30264681
[TBL] [Abstract][Full Text] [Related]
13. A Novel Approach to Flurbiprofen Pulsatile Colonic Release: Formulation and Pharmacokinetics of Double-Compression-Coated Mini-Tablets.
Vemula SK
AAPS PharmSciTech; 2015 Dec; 16(6):1465-73. PubMed ID: 26017285
[TBL] [Abstract][Full Text] [Related]
14. Press-Coated Aceclofenac Tablets for Pulsatile Drug Delivery: Formulation and In Vitro Evaluations.
Rashid R; Zaman M; Ahmad M; Khan MA; Butt MH; Salawi A; Almoshari Y; Alshamrani M; Sarfraz RM
Pharmaceuticals (Basel); 2022 Mar; 15(3):. PubMed ID: 35337124
[TBL] [Abstract][Full Text] [Related]
15. Novel sustained-release fast-disintegrating multi-unit compressed tablets of lornoxicam containing Eudragit RS coated chitosan-alginate beads.
Aburahma MH; Hamza Yel-S
Pharm Dev Technol; 2011 Aug; 16(4):316-30. PubMed ID: 20307250
[TBL] [Abstract][Full Text] [Related]
16. Design, characterization and in vivo performance of solid lipid nanoparticles (SLNs)-loaded mucoadhesive buccal tablets for efficient delivery of Lornoxicam in experimental inflammation.
Zewail MB; F Asaad G; Swellam SM; Abd-Allah SM; K Hosny S; Sallah SK; E Eissa J; S Mohamed S; El-Dakroury WA
Int J Pharm; 2022 Aug; 624():122006. PubMed ID: 35820515
[TBL] [Abstract][Full Text] [Related]
17. Formulation and evaluation of chondroitin sulphate tablets of aceclofenac for colon targeted drug delivery.
Ramasamy T; Subbaih Khandasamy U; Shanmugam S; Ruttala H
Iran J Pharm Res; 2012; 11(2):465-79. PubMed ID: 24250470
[TBL] [Abstract][Full Text] [Related]
18. Design and Evaluation of Chronomodulated Drug Delivery of Tramadol Hydrochloride.
Alekya T; Narendar D; Mahipal D; Arjun N; Nagaraj B
Drug Res (Stuttg); 2018 Mar; 68(3):174-180. PubMed ID: 28950389
[TBL] [Abstract][Full Text] [Related]
19. Preparation and pharmacokinetics evaluation of oral self-emulsifying system for poorly water-soluble drug Lornoxicam.
Li F; Song S; Guo Y; Zhao Q; Zhang X; Pan W; Yang X
Drug Deliv; 2015; 22(4):487-98. PubMed ID: 24524289
[TBL] [Abstract][Full Text] [Related]
20. Design of experiment approach for formulating multi-unit colon-targeted drug delivery system: in vitro and in vivo studies.
Shah N; Sharma OP; Mehta T; Amin A
Drug Dev Ind Pharm; 2016; 42(5):825-35. PubMed ID: 27019195
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
